
Results
19
Companies which are more than 50% undervalued based on analyst price target.
19 companies
ABL Bio
Market Cap: ₩5.0t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩89,100.00
7D
10.8%
1Y
15.4%
LigaChem Biosciences
Market Cap: ₩4.3t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩116,900.00
7D
6.4%
1Y
-21.0%
Voronoi
Market Cap: ₩3.2t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩176,500.00
7D
28.4%
1Y
50.2%
Hanall Biopharma
Market Cap: ₩2.9t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩56,900.00
7D
9.4%
1Y
110.0%
ST PharmLtd
Market Cap: ₩2.3t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩108,000.00
7D
7.2%
1Y
19.3%
L&C BIOLTD
Market Cap: ₩1.7t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩63,500.00
7D
8.2%
1Y
98.4%
Daewoong Pharmaceutical
Market Cap: ₩1.5t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩130,100.00
7D
5.3%
1Y
0.6%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩37,400.00
7D
8.1%
1Y
18.7%
HK inno.N
Market Cap: ₩1.2t
Engages in the pharmaceutical business in South Korea.
A195940
₩42,250.00
7D
8.6%
1Y
-3.5%
DongKook Pharmaceutical
Market Cap: ₩967.6b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩21,450.00
7D
17.7%
1Y
23.1%
Chong Kun Dang Pharmaceutical
Market Cap: ₩936.8b
Manufactures, markets, and sells medicines in South Korea and internationally.
A185750
₩71,100.00
7D
5.3%
1Y
-13.4%
Boryung
Market Cap: ₩779.8b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩9,230.00
7D
10.5%
1Y
10.5%
AprilBioLtd
Market Cap: ₩700.1b
Develops long-acting type biobetter and antibody biologics.
A397030
₩29,900.00
7D
17.7%
1Y
49.5%
Pharmicell
Market Cap: ₩695.4b
A biopharmaceutical company, develops and sells autologous drugs in South Korea and internationally.
A005690
₩11,590.00
7D
4.6%
1Y
-5.2%
Humedix
Market Cap: ₩290.0b
Engages in the manufacture and sale of various pharmaceutical products in South Korea.
A200670
₩28,100.00
7D
10.6%
1Y
-54.0%
BINEX
Market Cap: ₩244.0b
Operates as a pharmaceutical company in South Korea.
A053030
₩7,660.00
7D
11.8%
1Y
-53.2%
Whan In PharmLtd
Market Cap: ₩192.4b
Manufactures and sells various pharmaceutical products in South Korea.
A016580
₩10,410.00
7D
3.9%
1Y
-10.3%
Daewon Pharmaceutical
Market Cap: ₩176.8b
A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.
A003220
₩8,250.00
7D
7.3%
1Y
-37.2%
Macrogen
Market Cap: ₩137.9b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩12,720.00
7D
7.2%
1Y
-20.0%